ADMA Adma Biologics PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ADMA
- PE Ratio
As of May 30, 2025, the Adma Biologics stock's PE ratio is 22.55. This takes into account the latest EPS of $0.88 and stock price of $19.84. The PE ratio marks a decrease of 52% from its last 4 quarters average of 46.5.
ADMA PE ratio history
Adma Biologics PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 20.18 | N/A | $17.15 | $0.85 |
| 2023 | N/A | N/A | $4.52 | -$0.13 |
| 2022 | N/A | N/A | $3.88 | -$0.33 |
| 2021 | N/A | N/A | $1.41 | -$0.51 |
| 2020 | N/A | N/A | $1.95 | -$0.88 |
| 2019 | N/A | N/A | $4 | -$0.89 |
| 2018 | N/A | N/A | $2.39 | -$1.45 |
| 2017 | N/A | N/A | $3.21 | -$1.91 |
| 2016 | N/A | N/A | $5.12 | -$1.61 |
| 2015 | N/A | N/A | $8.07 | -$1.73 |
| 2014 | N/A | N/A | $11.17 | -$1.81 |
| 2013 | N/A | N/A | $7.8 | -$2.38 |
| 2012 | N/A | N/A | N/A | -$1.39 |
| 2011 | N/A | N/A | N/A | -$16.72 |
Adma Biologics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 22.55 | 11.74% | $19.84 | $0.88 |
| Dec 2024 | 20.18 | -70.72% | $17.15 | $0.85 |
| Sep 2024 | 68.93 | -7.51% | $19.99 | $0.29 |
| Jun 2024 | 74.53 | N/A | $11.18 | $0.15 |
| Mar 2024 | N/A | N/A | $6.6 | -$0.02 |
| Dec 2023 | N/A | N/A | $4.52 | -$0.13 |
| Sep 2023 | N/A | N/A | $3.58 | -$0.11 |
| Jun 2023 | N/A | N/A | $3.69 | -$0.2 |
| Mar 2023 | N/A | N/A | $3.31 | -$0.24 |
| Dec 2022 | N/A | N/A | $3.88 | -$0.33 |
| Sep 2022 | N/A | N/A | $2.43 | -$0.35 |
| Jun 2022 | N/A | N/A | $1.98 | -$0.4 |
| Mar 2022 | N/A | N/A | $1.83 | -$0.48 |
| Dec 2021 | N/A | N/A | $1.41 | -$0.51 |
| Sep 2021 | N/A | N/A | $1.13 | -$0.64 |
ADMA Price vs fair value
ADMA average PE ratio chart
ADMA PE vs peers
ADMA's PE ratio stands higher than its peer stock NVAX.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVAX Novavax Inc | 2.42 | $1.19B |
| ADMA Adma Biologics Inc | 22.55 | $4.74B |
| RGEN Repligen Corp | N/A | $6.63B |
| CVM Cel Sci Corp | N/A | $6.37M |
Frequently asked questions
What is Adma Biologics's PE ratio?
ADMA's price to earnings ratio is 22.55 as of May 30, 2025.
How is ADMA's PE ratio calculated (Adma Biologics PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 30, 2025), Adma Biologics's share price is $19.84. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.88. Therefore, Adma Biologics's PE ratio for today is 22.55. PE RATIO(22.55) = STOCK PRICE($19.84) / TTM EPS($0.88)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.